Organon to Present New Research on Access and Value at ISPOR 2026
RA: NAV Erosion Will Continue Even When Interest Rates Decline
Brookfield Real Assets Income Fund Inc. Declares Q2 2026 Distribution Schedule
Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Change
Brookfield Real Assets Income Fund Inc. $RA Position Increased by Penserra Capital Management LLC
RA: 10% Yield Not As Good As It Looks
FMB WEALTH MANAGEMENT Buys 5,592 Shares of AnaptysBio Inc (ANAB)
Brookfield Real Assets Income Fund Inc. Declares Q1 2026 Distribution Schedule
Raphael Pharmaceutical Announces Filing of Provisional Patent Application for the Treatment of Neutrophil-Dominant Autoimmune Diseases, Including Rheumatoid Arthritis (RA)
RA: The Fund Is Paying Out More Than It Earns (Rating Downgrade)
Brookfield Real Assets Income Fund Inc. Announces Portfolio Manager Update Webcast
Adicet Bio Announces First Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Treatment-Refractory Rheumatoid Arthritis (RA)
Brookfield Real Assets Income Fund Inc. Declares Q4 2025 Distribution Schedule
RA: Collect Income From Real Assets
Brookfield Real Assets Income Fund Inc. Announces Quarterly Webcast
Brookfield Real Assets Income Fund Inc. Declares Q3 2025 Distribution Schedule
RA: High Debt Allocation Is A Problem Here
Brookfield Real Assets Income Fund Inc. Announces Quarterly Webcast
Brookfield Real Assets Income Fund Inc. Declares Q2 2025 Distribution Schedule
RA: Discounted With A 10%+ Distribution Rate
Brookfield Real Assets Income Fund Inc. Announces Portfolio Management Team Changes
Brookfield Real Assets Income Fund Inc. Announces Quarterly Webcast
CEF Insights: Opportunities For Income With Real Assets
Brookfield Real Assets Income Fund Inc. Declares Q1 2025 Distribution Schedule
RA: Fixed-Income Is Not The Best Way To Play Infrastructure
Brookfield Real Assets Income Fund Inc. Announces Quarterly Webcast
Brookfield Real Assets Income Fund Inc. Declares Q4 2024 Distribution Schedule
RA: Still Attractive On A Relative Basis Despite Narrowing Discount
Brookfield Real Assets Income Fund Inc. Announces Portfolio Manager Update Webcast
Coming Bond Rally ‘Sequel' Will Send These 8%+ Dividends Soaring
Brookfield Real Assets Income Fund Inc. Declares Q3 2024 Distribution Schedule
Brookfield Real Assets: A Good Point To Exit This 11% Yielder
Brookfield Real Assets Income Fund Inc. Announces Portfolio Manager Update Webcast
Across 219+ Pages on Rheumatoid Arthritis Drugs Market’s Surge to Over $62,935 Million by 2027
NIMML Institute Presents Pioneering Research on Immunometabolic Mechanisms Related to the Pharmacological Activation of LANCL Receptors at Immunology2024, the Annual Meeting of the American Association of Immunologists
RA: Reiterate Avoid Recommendation
Brookfield Real Assets: 10% Yield And A Large Discount Are Not Enough
Brookfield Real Assets Income Fund Inc. Declares Q2 2024 Distribution Schedule and Announces Fund Updates
Bonds Are Boring? Not When They Throw Off 10%+ Dividends
Brookfield Real Assets Income Fund Inc. Announces Portfolio Manager Update Webcast
RA: Discount Continues To Leave Some Opportunity
CEF Weekly Commentary | Swap Some MAIN Bonds?
Brookfield Real Assets Income Fund Inc. Declares Q1 2024 Distribution Schedule
Brookfield Real Assets Vs SJNK: Birds Of A Feather
Brookfield Real Assets Income Fund Inc. Announces Portfolio Manager Update Webcast
This Monthly-Paying Mini-Portfolio Delivers 11.1% Each Year
RA: Big Cut Leads To Opportunity
5 Closed-End Fund Buys In The Month Of August 2023 (Plus 2 I Sold)
This Fund Just Chopped Its Dividend 40% (5 Key Takeaways)
CEF Market Weekly Review: How Underperforming Funds End Up At High Premiums